NASDAQ OMX

SAP to Showcase Digital Innovation at SAP Leonardo Live Event

31.5.2017 10:00 | NASDAQ OMX

Dela

WALLDORF, Germany, May 31, 2017 (GLOBE NEWSWIRE) --  SAP MARKETFLASH   --   SAP SE (NYSE: SAP) today announced that registration is available for its first-ever global digital innovation conference, SAP Leonardo Live. With technologies like Internet of Things (IoT), machine learning, blockchain, Big Data and analytics converging to dramatically transform the way people live and work, the SAP event will showcase leading innovations, industry expertise and best-practice business cases from around the globe. SAP Leonardo Live will take place on July 11 and 12 at the Kap Europa Congress Center in Frankfurt, Germany.  Registration is available at www.delegate.com/sap/leonardolive/2017/.

"We are assembling the world's leading companies, technology vendors and industry visionaries to examine both the enormous potential and the tangible business value that can be achieved through digital innovation," said Mala Anand, EVP, President, SAP Leonardo. "SAP Leonardo Live will set an industry standard for peer-to-peer networking, creating a productive environment for learning, exchanging ideas and thinking big about digital innovation." 

Recently launched at SAPPHIRE NOW 2017 as SAP's new digital innovation system, SAP Leonardo brings together differentiating software capabilities in machine learning, the Internet of Things (IoT), Big Data, analytics and blockchain on SAP Cloud Platform together with SAP experience, deep process and industry knowledge, and advanced design thinking methodology. With dozens of industry awards and recognitions, each of these areas of SAP's portfolio can add tremendous value for our customers on their digital journey - but the real power is when they all work together.

SAP Leonardo is built on SAP Cloud Platform and harnesses SAP's deep process and industry expertise, extensive software portfolio and expertise in emerging technologies to help customers manage digital business transformation.  While many organizations see the potential of faster innovation and higher profitability from adopting digital business models, they often lack clarity on where to begin and how to integrate new approaches within their existing business. At SAP Leonardo Live, SAP will convene its powerful community of customers, partners and the industry's leading voices to help attendees see and understand how to adopt digital innovation that can scale across the entire organization.

"At SAP Leonardo Live, attendees can learn from experts who have already started their digital transformation and are already using cutting edge technologies in their businesses," said Dr. Tanja Rueckert, President, IoT and Digital Supply Chain, SAP. "Companies of all sizes from diverse industries around the world will be on hand to share best practices, lessons learned, industry knowledge and business expertise. Attendees can experience these new technologies through hands-on workshops and discover how SAP solutions can enable new digital models."

The two-day event will connect leaders of the business world on one central stage, featuring more than 50 companies from all over the world to discuss their digital innovation strategies.  Agenda highlights of SAP Leonardo Live include:

  • A comprehensive overview of our SAP Leonardo digital innovation portfolio and its concrete benefits for business
  • Best practices from SAP customers in multiple industries, including Adidas, Hewlett Packard Enterprise, Hilti, KAESER Kompressoren SE, and Stara
  • Compelling use cases powered by SAP Leonardo to improve the way it makes, designs, plans, delivers and maintains products and assets across a global network
  • Exclusive peer-to-peer discussions and networking with thought leaders and business and technology experts
  • Design thinking experts to demonstrate how new technologies like machine learning, IoT, analytics can work seamlessly together for your organization.

For more information, check out the SAP Leonardo Live website and follow the event on Twitter / LinkedIn and at the official hashtag, #leonardolive, for more updates.

For more information, visit the SAP News Center. Follow SAP on Twitter at @sapnews.

Media Contacts:
Kathrin Eiermann, SAP, +49 6227 74 07 79, simone.kathrin.eiermann@sap.com, CET
Jim Dever, SAP, +1 (610) 661-2161, james.dever@sap.com, EDT
SAP News Center press roompress@sap.com 
Kyle Tildsley, PAN Communications, +1 (617) 503-4352, ktildsley@pancomm.com, EDT

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP's future financial results are discussed more fully in SAP's filings with the U.S. Securities and Exchange Commission ("SEC"), including SAP's most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.

© 2017 SAP SE. All rights reserved. 
SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see http://www.sap.com/corporate-en/legal/copyright/index.epx#trademark for additional trademark information and notices.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SAP Global Marketing via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste nyheterna från NASDAQ OMX

LifeSci Advisors' Board Placement Initiative Announces Ninth Board Placement23.6.2017 17:52Pressmeddelande

NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, a leading life sciences-focused investor relations consultancy, announced today the ninth placement of a female executive to a life sciences company board as part of their Board Placement Initiative (BPI), a program launched a year ago with the goal to connect female executives in the life sciences industry with companies looking for board candidates. LifeSci is pleased to share news of the appointment of Jean M. Franchi to the Board of Directors of Biophytis, a biotech company listed on Euronext Paris (ALBPS) focused on drugs that target diseases of aging, with drug candidates in clinical development for dry AMD and Sarcopenia. "I'm honored to join the Biophytis board, and look forward to helping the company achieve a more global presence as it advances its portfolio of innovative therapies addressing unmet needs associated with aging," said Ms. Franchi. "I want to extend my kind thanks to LifeSci

Fentress Architects Announces its Annual Student Global Challenge23.6.2017 09:00Pressmeddelande

6th edition invites students to re-envision the terminal building in the year 2075 Denver, Colorado, June 23, 2017 (GLOBE NEWSWIRE) -- Fentress Architects, based in Denver, Colorado, announces the 2017 Fentress Global Challenge, an international design competition for young and student architects. As in years past, the theme, consistent with the firm's expertise in airport design and aviation, is envisioning an airport of the future.  Participants are encouraged to re-envision the terminal building in the year 2075 using one of 10 existing international airports, taking into consideration local context, technological trends, and project feasibility and passenger experience. This is the sixth year that Fentress Architects has sponsored and administered the award, which brings a First Prize of $15,000 and a summer internship at Fentress' Denver office; four additional winners will receive smaller cash awards.

Oxford Immunotec Announces National Reimbursement for the T-SPOT®.TB Test in France22.6.2017 22:50Pressmeddelande

OXFORD, United Kingdom and MARLBOROUGH, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced a decision from the French Ministry of Health and Social Affairs to reimburse interferon gamma release assays, or IGRAs, for latent TB screening in at risk patient populations. Upon implementation of the new reimbursement codes, which is expected in the next 21 days, the French Ministry of Health and Social Affairs will provide reimbursement for the T-SPOT. TB  test at a rate of approximately 60 Euros per test. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-r

Standard Lithium Raises $7.4 Million in Oversubscribed Financing22.6.2017 21:49Pressmeddelande

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 22, 2017 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLL) (FRA:S5L) is pleased to announce that it has completed the private placement of 9,894,785 common shares at a price of $0.75 per share for gross proceeds of $7,421,089.  Interest in the placement far exceeded the expectations of the Company, and the additional amount raised provides the Company with the capital needed to advance its current projects and pursue strategic acquisitions in the lithium sector. "We are extremely pleased with the interest received in this placement, and completion represents a significant milestone for the Company," commented Anthony Alvaro, a director of the Company.  "The strong demand speaks to the growing confidence in our team, projects and futur

IAGC: Plankton Study Speculative and Needs Better Data22.6.2017 16:08Pressmeddelande

Houston, TX, US, June 22, 2017 (GLOBE NEWSWIRE) -- The International Association of Geophysical Contractors (IAGC) released the following statement regarding the publishing of research on the interaction of seismic surveys and zooplankton in Nature: Ecology and Evolution. The IAGC President, Nikki Martin issued the following statement: "While we found the study interesting, we are also troubled by the small sample sizes, the large day-to-day variability in both the baseline and experimental data, and the large number of speculative conclusions that appear inconsistent with the data collected over a two-day period.  Both statistically and methodologically, this project falls short of what would be needed to provide a convincing case for adverse effects from geophysical survey operations.  "Although the initial report is peer-reviewed, it has not been widely accepted by the expert scientific community.  We look forward to discussing this topic further with

Minerva Announces Completion of Bridging Study to Select Improved Formulation of MIN-101 for Use in Phase 3 Trial for the Treatment of Negative Symptoms in Patients With Schizophrenia22.6.2017 14:30Pressmeddelande

New formulation observed to improve safety margin while offering bioequivalent exposure to prior formulation Company to proceed with initiation of Phase 3 trial on schedule in second half of 2017 CMC scale-up work for NDA preparation initiated WALTHAM, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced the successful completion of a bridging trial to select an improved, gastric-resistant (GR) formulation of MIN-101. The Company plans to use the selected formulation in its upcoming Phase 3 clinical trial, which remains on schedule for initiation in the second half of 2017, as well as for the potential future submission of a New Drug Application (NDA). 

I vårt nyhetsrum kan du läsa de senaste nyheterna, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt nyhetsrum